2003
DOI: 10.1016/s0016-5085(03)81999-6
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
1
0
4

Year Published

2004
2004
2007
2007

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
1
0
4
Order By: Relevance
“…With this in mind, it is important to compare HRQOL among different populations using disease-specific instruments that focus on the factors most relevant to the disease, are more sensitive to the impact of the symptoms on the QOL, which can be underestimated by generic instruments, and are more appropriate for treatment trials [1,7]. In fact, in a previous study based on IBS patients from tertiary referral centers, it was found that Mexican patients reported longer flare-ups and more physician visits during the previous year compared to patients from Los Angeles but there were no differences in HRQOL assessed by a generic instrument, the SF-36 [23].…”
Section: Hrqol In Mexican Female Ibs Patientsmentioning
confidence: 99%
“…With this in mind, it is important to compare HRQOL among different populations using disease-specific instruments that focus on the factors most relevant to the disease, are more sensitive to the impact of the symptoms on the QOL, which can be underestimated by generic instruments, and are more appropriate for treatment trials [1,7]. In fact, in a previous study based on IBS patients from tertiary referral centers, it was found that Mexican patients reported longer flare-ups and more physician visits during the previous year compared to patients from Los Angeles but there were no differences in HRQOL assessed by a generic instrument, the SF-36 [23].…”
Section: Hrqol In Mexican Female Ibs Patientsmentioning
confidence: 99%
“…En Latinoamérica, en estudios basados en la comunidad, la prevalencia de SII en Brasil, Colombia, México y Uruguay osciló entre el 9 y el 18% [18][19][20][21][22][23] . La edad de presentación de los pacientes con SII tiene un amplio rango, de 16 a 89 años, con un promedio de 42 años 19,[23][24][25][26] . La distribución por sexos del SII en la comunidad es de 2 a 4 mujeres por cada varón 20,[23][24][25] , y afecta aproximadamente a un 15% de las mujeres y a un 5% de los varones.…”
Section: Prevalenciaunclassified
“…La edad de presentación de los pacientes con SII tiene un amplio rango, de 16 a 89 años, con un promedio de 42 años 19,[23][24][25][26] . La distribución por sexos del SII en la comunidad es de 2 a 4 mujeres por cada varón 20,[23][24][25] , y afecta aproximadamente a un 15% de las mujeres y a un 5% de los varones. Según las encuestas, sólo entre el 10 y el 50% de las personas que presentan SII consultan al médico; son los denominados «pacientes», en contraposición a los «no pacientes», que son los individuos que cumplen con los criterios diagnósticos del SII, pero que no buscan atención médica.…”
Section: Prevalenciaunclassified
See 2 more Smart Citations